Lung cancer screening and its implications
Professor Bob Steele CBE (Dundee, UK) discusses the potential implementation of a National Screening Programme in the UK, and the view post-NELSON, as well as highlighting the next steps in… read more.
Professor Bob Steele CBE (Dundee, UK) discusses the potential implementation of a National Screening Programme in the UK, and the view post-NELSON, as well as highlighting the next steps in… read more.
by Christine Clark ISHL 2016 Professor Joseph Connors (Vancouver) speaks about the session at ISHL10 where a world view of the management of Hodgkin lymphoma was discussed. There… read more.
Pathophysiology and diagnosis of multiple myeloma bone disease Evangelos Terpos, University of Athens School of Medicine, Greece Osteolytic bone disease is the most common complication of MM and… read more.
Pathophysiology and diagnosis of multiple myeloma bone disease Evangelos Terpos, University of Athens School of Medicine, Greece Osteolytic bone disease is the most common complication of MM and… read more.
by Bruce Sylvester: One dosing with methylene blue appears to increase MRI-based response in brain areas that control short-term memory and attention, researchers reported on June 28 in… read more.
by Bruce Sylvester: Researchers report that in most cases hip x-rays are unreliable for diagnosing hip osteoarthritis (OA). The findings appeared on Dec. 8, 2015 in the British Medical… read more.
by Sanjay Tanday: Advances in diagnostics and therapy means the prospects of living a normal active life free of symptoms and disability are better than ever for IBD… read more.
by Sanjay Tanday: Advances in diagnostics and therapy means the prospects of living a normal active life free of symptoms and disability are better than ever for IBD… read more.
In a study of nearly 2,000 adults, researchers found that a build up of plaque in the body’s major arteries was associated with mild cognitive impairment. Results of… read more.
by Bruce Sylvester – The selective serotonin reuptake inhibitor (SSRI) citalopram appears to impede development of amyloid beta, a plaque-forming peptide in the brain believed to be involved… read more.
by Bruce Sylvester – The selective serotonin reuptake inhibitor (SSRI) citalopram appears to impede development of amyloid beta, a plaque-forming peptide in the brain believed to be involved… read more.
In up to 85 percent of cases. “The substantial numbers of patients misdiagnosed and under diagnosed in this study is a cause for concern. It is important that… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.